We found similar results in the Validation Group: CTNNB was significantly more abundant in 23 HCC patients (median = 1652 pg/ml) compared to 22 chronic hepatitis patients (median = 680 pg/ml) (p = 0.020) (Fig. 4C). The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.